Literature DB >> 19207551

Is the etiology of eosinophilic esophagitis in adults a response to allergy or reflux injury? Study of cellular proliferation markers.

C J Lewis1, C A Lamb, V Kanakala, S Pritchard, G R Armstrong, S E A Attwood.   

Abstract

Recent research suggests that allergy may be the key factor in the etiology of eosinophilic esophagitis (EE); however, historically, the condition was hypothesized as related to reflux injury to the esophageal mucosa. We studied this hypothesis by comparing markers of inflammation and cellular proliferation in EE and reflux esophagitis. Lower esophageal biopsies of adult patients with EE (n = 10), reflux esophagitis (n = 8), and normal controls (n = 13) were assessed quantitatively for the expression of the cyclooxygenase-2 (COX-2) enzyme, cellular proliferation, and oncogenic resistance to apoptosis using monoclonal antibodies for COX-2, Ki-67, and Bcl-2, respectively. Normal esophageal epithelium demonstrated weak diffuse uptake of COX-2 stain in the basal layer. No COX-2 expression was demonstrated in the EE group, significantly less than the control and reflux groups (P < 0.01 and P < 0.001, respectively). Cellular proliferation measured by Ki-67 expression was higher in EE and reflux compared with control (P < 0.001 and P < 0.01). Ki-67 expression, and thus degree of hyperplasia, appeared greater in EE than reflux, but was not statistically significant (P = 0.228). The degree of apoptosis was similar in all study groups. EE and reflux esophagitis are proliferative conditions expressing Ki-67 in higher concentrations than control. Mucosal proliferation in reflux esophagitis is COX-2 dependent. This novel research in EE has demonstrated downregulation of COX-2 expression compared with reflux esophagitis and control. We hypothesize that the allergy-related cytokine IL-13 known to inhibit COX-2 expression and found in high concentrations in EE as responsible for this. The pathogenesis of EE is likely dependent on allergy rather than reflux injury to the esophagus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19207551     DOI: 10.1111/j.1442-2050.2008.00896.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.

Authors:  Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

Review 3.  Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.

Authors:  Mahsa Eskian; MirHojjat Khorasanizadeh; Amal H Assa'ad; Nima Rezaei
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

4.  Clinical lesson: eosinophilic oesophagitis, a new diagnosis to swallow.

Authors:  C A Lamb; V Kanakala; R W Stirling; S E A Attwood
Journal:  Frontline Gastroenterol       Date:  2010-04-01

5.  Current hurdles in the management of eosinophilic oesophagitis: the next steps.

Authors:  Stephen Ea Attwood; Michael Sj Wilson
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

6.  Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis.

Authors:  Gregory Constantine; Neha Seth; Niti Chokshi; Charles G Minard; Danielle Guffey; Anthony P Olive; Carla M Davis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-06       Impact factor: 2.839

Review 7.  Eosinophilic oesophagitis: clinical presentation and pathogenesis.

Authors:  Jonas Bystrom; Nuala R O'Shea
Journal:  Postgrad Med J       Date:  2014-03-19       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.